A carregar...
Treatment of Complications from Immune Checkpoint Inhibition in Patients with Lung Cancer
Immune checkpoint inhibitors have revolutionized the management of advanced NSCLC. With the intention of generating an anti-tumor immune response, ICIs can also lead to inflammatory side effects involving a wide variety of organs in the body, termed immune-related adverse events. Although no prospec...
Na minha lista:
| Publicado no: | Curr Treat Options Oncol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer US
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7102206/ https://ncbi.nlm.nih.gov/pubmed/30101402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-018-0562-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|